Kidney Disease: Clinical Trials

19 trials for Kidney Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 3 not yet recruiting, 1 recruiting, 1 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Completed 14, Not yet recruiting 3, Recruiting 1, Terminated 1

Follow Kidney Disease: new trials by email Literature Review of Kidney Disease trials Research Report on Kidney Disease

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Montelukast, Placebo - Diabetes, Kidney Disease
Phase 4Not yet recruitingUniversity of Colorado, Denver1102026-09-012026-07-06
The Clinical Research of Traditional Chinese Medicine Formula
Bushen Huoxue Simiao Formula, control group - Urologic Injuries, Kidney Disease
Phase 4Not yet recruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine802026-08-312026-08-04
Randomized Trial of SGLT2i in Heart Transplant Recipients
Empagliflozin, Placebo - Heart Transplant, Cardiovascular Disease
Phase 4RecruitingVA Office of Research and Development2002026-01-202026-01-22
Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation
Linezolid (IV and PO) - Kidney Disease
Phase 4Not yet recruitingAlexandria University502025-10-152025-08-24
Effects of Dexmedetomidine on Microcirculation of Kidney Transplant Recipient
Dexmedetomidine - Kidney Disease
Phase 4CompletedNational Taiwan University Hospital602016-08-012020-12-17
Whole Body Vibration in Kidney Disease
Whole Body Vibration - Kidney Disease
Phase 4CompletedUniversidade Federal de Pernambuco162015-04-012016-11-15
ISCHEMIA-Chronic Kidney Disease Trial
Cardiac Catheterization, Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention - Cardiovascular Diseases, Coronary Artery Disease
Phase 4CompletedNYU Langone Health7772014-01-012021-10-18
Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
Aliskiren, Placebo - Kidney Disease, Kidney Failure, Chronic
Phase 4TerminatedBrigham and Women's Hospital102010-04-012017-05-01
Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease
Aliskiren, Losartan - Kidney Disease
Phase 4CompletedThe University of Hong Kong802009-07-012015-07-03
Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
Placebo, Allopurinol - Kidney Disease, Left Ventricular Hypertrophy
Phase 4CompletedA. D. Struthers672008-01-012016-11-03
Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis
DIANEAL, EXTRANEAL - End-stage Renal Disease (ESRD), Kidney Disease
Phase 4CompletedOttawa Hospital Research Institute502007-07-012021-03-15
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
cinacalcet - Chronic Kidney Disease, End Stage Renal Disease
Phase 4CompletedAmgen3602006-09-012014-07-23
START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Sensipar - Kidney Disease, Secondary Hyperparathyroidism
Phase 4CompletedAmgen3002004-07-012009-02-13
Angiotensin II Blockade for Chronic Allograft Nephropathy
Losartan 100mg, Placebo - Kidney Disease, Proteinuria
Phase 4CompletedUniversity of Minnesota1532002-12-012017-09-18
STAAR-3 Clinical Study
Darbepoetin alfa - Chronic Kidney Disease, Chronic Renal Insufficiency
Phase 4CompletedAmgen4432002-05-012010-02-19
STAAR-1 Clinical Study
darbepoetin alfa - Chronic Kidney Disease, Chronic Renal Insufficiency
Phase 4CompletedAmgen20002002-02-012009-10-16
STAAR-2 Clinical Study
Darbepoetin alfa - Chronic Kidney Disease, Chronic Renal Insufficiency
Phase 4CompletedAmgen6182002-01-012010-03-05
Study to Evaluate Effectiveness of Aranesp®
Aranesp® - Kidney Disease
Phase 4CompletedAmgen2011-01-21
Aranesp® Monthly Preference Study - 2
Aranesp® - Kidney Disease
Phase 4CompletedAmgen2008-09-30

Narrower conditions

Kidney Diseases (19)  ·  Renal Insufficiency, Chronic (7)  ·  Anemia (3)  ·  Cardiovascular Diseases (3)  ·  Kidney Failure, Chronic (3)  ·  Hyperparathyroidism, Secondary (2)  ·  Patient Preference (2)  ·  Proteinuria (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Calcinosis (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Heart Diseases (1)  ·  Hyperparathyroidism (1)  ·  Hypertrophy, Left Ventricular (1)

Broader conditions

Female Urogenital Diseases (19)  ·  Female Urogenital Diseases and Pregnancy Complications (19)  ·  Male Urogenital Diseases (19)  ·  Urogenital Diseases (19)  ·  Urologic Diseases (19)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Chronic Disease (9)  ·  Disease Attributes (9)  ·  Pathologic Processes (9)  ·  Renal Insufficiency (9)  ·  Endocrine System Diseases (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Behavior (2)  ·  Cardiovascular Diseases (2)

Interventions

Darbepoetin alfa (5)  ·  Cinacalcet (2)  ·  Control Groups (2)  ·  Losartan (2)  ·  aliskiren (2)  ·  Allopurinol (1)  ·  Cardiac Catheterization (1)  ·  Coronary Artery Bypass (1)  ·  Dexmedetomidine (1)  ·  Dosage Forms (1)  ·  Drug Therapy (1)  ·  Icodextrin (1)  ·  Linezolid (1)  ·  Percutaneous Coronary Intervention (1)  ·  Vitamin D (1)

Sponsors

Amgen (7)  ·  A. D. Struthers (1)  ·  Alexandria University (1)  ·  Brigham and Women's Hospital (1)  ·  NYU Langone Health (1)  ·  National Taiwan University Hospital (1)  ·  Ottawa Hospital Research Institute (1)  ·  The Fourth Affiliated Hospital of Zhejiang University School of Medicine (1)  ·  The University of Hong Kong (1)  ·  Universidade Federal de Pernambuco (1)  ·  University of Colorado, Denver (1)  ·  University of Minnesota (1)  ·  VA Office of Research and Development (1)

Countries

United States (5)  ·  Canada (1)  ·  China (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Allan D Struthers, BSc, MD, FRCP, FESC (1)  ·  Anil Chandraker, MD (1)  ·  Bertram Kasiske, M.D. (1)  ·  David Maron, MD (1)  ·  Harmony Reynolds, MD, MHA (1)  ·  Hassan N. Ibrahim, M.D., M.S. (1)  ·  Helen KB Fuzari, MD (1)  ·  Jessica Kendrick, MD MPH (1)  ·  Josef Stehlik, MD MPH (1)  ·  Judith Hochman, MD (1)  ·  Marcel Ruzicka, MD, PhD (1)  ·  Sydney CW Tang, MD (1)  ·  Yu-Chang Yeh, PhD (1)

Results publications

PMID 18328118, PMID 23965522, PMID 24457184, PMID 32227754, PMID 32227756, PMID 33989711, PMID 35261290, PMID 35973009, PMID 36193750, PMID 36697158, PMID 39082471

NIH funding

R01DK060706 (1), U01HL117905 (1)